Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT05917418
Starting soon Not applicable

Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk

NCT05917418 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College
Phase
Not applicable
Started
2026-12-01
Last updated
2026-01-09

Condition(s) studied

Malnutrition

Investigational drug(s) / intervention(s)

nutritional support

nutritional support: nutritional support

Study summary

The impact of nutritional support for the patients at nutritional risk on clinical outcomes and cost-effectiveness.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * patients be in hospital overnight * diagnoses according to the protocol of cohort study for cost effectiveness Exclusion Criteria: * patients admitting from emergency department * patients who undergone operation before second morning of hospitalization * patients who dose not give Informed Consents

Primary outcome measure(s)

  • The incidence of Infectious complication — during the hospital stay
    A infectious complication was defined as as the presence of recognized pathogens in body tissues that normally are sterile, confirmed by the results of culture and supported by clinical, radiologic or hematologic evidence of infection

Trial sites (2)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing Beijing Municipality
Beijing Chest Hospital, Capital Medical University Beijing Beijing Municipality

More Peking Union Medical College trials in China

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing Recruiting
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway Starting soon
Tooth and Bone-borne Cutting/Repositioning Guide and Patient-specific Implant(PSI) Recruiting
Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning Recruiting
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa Recruiting

Other trials for the same condition

Washed Microbiota Transplantation for Malnutrition Recruiting
Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk Recruiting
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT Active, not recruiting
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy Starting soon
Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05917418 on ClinicalTrials.gov ↗ ← All trials in China